ANAHEIM, Calif., Jan. 29, 2020 (GLOBE NEWSWIRE) -- At MD&M West, Trelleborg’s healthcare & medical operation will exhibit advanced polymer solutions for healthcare and medical applications. From February 11 to 13, in Hall D at Booth 2601, Trelleborg will demonstrate how it helps pharmaceutical and medical device companies improve patient quality of life by forming lasting partnerships with customers to develop innovative, reliable engineered polymer solutions for demanding medical, biotech and pharmaceutical applications.
For more than 20 years, Trelleborg has developed and supplied silicone tubing, film and custom-molded components, as well as elastomer and polymer seals, to manufacturers for their biotech and pharmaceutical equipment, and medical devices. Trelleborg’s healthcare & medical operation brings together all its global sales, development, design and manufacturing facilities to better meet its customers’ needs.
Linda Muroski, Global President, Trelleborg’s healthcare & medical operation, says, "We are focusing our global expertise in healthcare and medical to provide our customers the industry-specific solutions they require. Creating a healthcare & medical operation strengthens our ability to respond even faster to customers’ requests, whether they be for new innovations, expanded capabilities or potential geographical expansion.
“We partner with customers from the initial design phase through prototyping and commercialization, utilizing our engineering and material expertise and global portfolio of manufacturing capabilities to meet customer needs at every stage of development. This accelerates time to market for new medical devices. And to ensure those medical devices and services meet customer and regulatory requirements, all of our healthcare and medical facilities conform to ISO 13485-2016.
“Trelleborg manufacturing facilities specialize in producing custom silicone and thermoplastic components, including micro-molded parts, parts with complex geometries and multi-component parts. Our in-house tool rooms develop high precision Liquid Silicone Rubber (LSR) tooling combined with advanced automation technologies to support production volumes ranging from prototype to high-volume serial production.”
At MD&M West, Trelleborg will showcase its medical silicone tubes for long-term implants. Due to their biocompatibility and physical resistance, they play an important role in medical applications, both as conduits to transport liquid and as insulators for cables and sensors. The products must meet high-precision control and process stability demands, and also be implantable for up to several years. All long-term implantable silicone products are processed in cleanroom environments.
Trelleborg has developed a range of specialty tubing and hose. Tubes are available in a full range of sizes and are designed jointly with customers to meet their individual application needs. Examples include multi-lumen, flexible, kink-resistant and silicone tubing with a plastic core for minimally invasive instruments, catheters and probes.
Trelleborg’s patented GeoTransTM technology enables a significantly greater variation in the geometry of tubing, supporting unique, customer-specific designs. For example, one lumen can be separated into two lumen (or two into one) during the extrusion process, eliminating the need for a molded component between the different segments. Additionally, lumen can be stopped and restarted or the dimensions of tubing can be changed, which is often necessary for wound drains. Reducing the process steps in manufacturing saves time and decreases potential sources of failure, thereby reducing costs and mitigating risk.
Also on display at MD&M West are Trelleborg’s silicone sheeting and film capabilities, which address the increasing demand for flexible, breathable wound dressings to minimize scarring, reduce the risk of infection and accelerate healing.
"Depending on the medical application, wafer-thin silicone gel films containing active pharmaceutical ingredients are being increasingly used in place of more traditional burn and wound care treatments," says Drew Gaillard, Global Director, Trelleborg’s healthcare & medical operation. "The silicone film can be combined with antibiotics or decongestants, which can potentially replace epidermally applied medication. These drug-eluting silicone films significantly improve treatment for the patients."
Trelleborg experts will be in Hall D, Booth 2601 at MD&M West in Anaheim, CA, February 11-13 to discuss all of the company’s solutions for the healthcare and medical. For further details regarding Trelleborg’s healthcare & medical operations, go to <www.tss.trelleborg.com/healthcare>.
For more information or high-resolution pictures, please contact:
Media Contact:
Dawn Fontaine
Ripple Effect Communications
Tel: +1 617-536-8887
Email: dawn@RippleEffectPR.com
Corporate Contact:
Mike O’Brien
Trelleborg Sealing Solutions
Tel: +1 224-443-2967
Email: mike.obrien@trelleborg.com
About Trelleborg Healthcare & Medical and Trelleborg Group
Trelleborg Healthcare & Medical helps pharmaceutical and medical device companies improve patient quality of life. It does this by forming lasting partnerships with customers to develop innovative, reliable engineered polymer solutions for demanding medical, biotech and pharmaceutical applications. From a single global source, backed by the expertise of a worldwide engineering and manufacturing network, it partners with its customers in all stages of development, from concept to serial production, providing the optimum solutions to meet all their partners polymer-based healthcare & medical application challenges. Trelleborg Healthcare & Medical combines a number of operations from within Trelleborg Group that are focused on this industry. www.tss.trelleborg.com/healthcare
Trelleborg is a world leader in engineered polymer solutions that seal, damp and protect critical applications in demanding environments. Its innovative solutions accelerate performance for customers in a sustainable way. The Trelleborg Group has annual sales of about SEK 34 billion (EUR 3.32 billion, USD 3.92 billion) and operations in about 50 countries. The Group comprises three business areas: Trelleborg Industrial Solutions, Trelleborg Sealing Solutions and Trelleborg Wheel Systems, and a reporting segment, Businesses under development. The Trelleborg share has been listed on the Stock Exchange since 1964 and is listed on Nasdaq Stockholm, Large Cap. www.trelleborg.com.